| Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens G Sauter, S Steurer, TS Clauditz, T Krech, C Wittmer, F Lutz, M Lennartz, ... European urology 69 (4), 592-598, 2016 | 292 | 2016 |
| Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer A Woolston, K Khan, G Spain, LJ Barber, B Griffiths, R Gonzalez-Exposito, ... Cancer cell 36 (1), 35-50. e9, 2019 | 207 | 2019 |
| The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... Journal for immunotherapy of cancer 8 (1), 2020 | 192 | 2020 |
| MRI tumor regression grade and circulating tumor DNA as complementary tools to assess response and guide therapy adaptation in rectal cancer S Khakoo, PD Carter, G Brown, N Valeri, S Picchia, MA Bali, R Shaikh, ... Clinical Cancer Research 26 (1), 183-192, 2020 | 90 | 2020 |
| CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer … R Gonzalez-Exposito, M Semiannikova, B Griffiths, K Khan, LJ Barber, ... Journal for immunotherapy of cancer 7, 1-14, 2019 | 78 | 2019 |
| Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma F Gebauer, M Tachezy, K Effenberger, K von Loga, H Zander, A Marx, ... Journal of surgical oncology 104 (2), 140-145, 2011 | 66 | 2011 |
| Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer K von Loga, A Woolston, M Punta, LJ Barber, B Griffiths, M Semiannikova, ... Nature communications 11 (1), 139, 2020 | 61 | 2020 |
| Ultra-sensitive mutation detection and genome-wide DNA copy number reconstruction by error-corrected circulating tumor DNA sequencing S Mansukhani, LJ Barber, D Kleftogiannis, SY Moorcraft, M Davidson, ... Clinical chemistry 64 (11), 1626-1635, 2018 | 53 | 2018 |
| CXCR7 expression in esophageal cancer M Tachezy, H Zander, F Gebauer, K von Loga, K Pantel, JR Izbicki, ... Journal of translational medicine 11, 1-6, 2013 | 44 | 2013 |
| Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus MF Nentwich, K von Loga, M Reeh, FG Uzunoglu, A Marx, JR Izbicki, ... Journal of Gastrointestinal Surgery 18 (2), 242-249, 2014 | 40 | 2014 |
| MALDI imaging on large‐scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer A Quaas, AS Bahar, K von Loga, AS Seddiqi, JM Singer, M Omidi, ... Histopathology 63 (4), 455-462, 2013 | 31 | 2013 |
| PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma HM Ameis, A Drenckhan, K von Loga, G Escherich, K Wenke, JR Izbicki, ... PLoS One 8 (12), e83701, 2013 | 28 | 2013 |
| An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma M Reeh, MF Nentwich, K von Loga, J Schade, FG Uzunoglu, AM Koenig, ... The Annals of thoracic surgery 93 (3), 890-896, 2012 | 27 | 2012 |
| Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer A Wilkins, E Fontana, G Nyamundanda, C Ragulan, Y Patil, D Mansfield, ... Journal for immunotherapy of cancer 9 (3), 2021 | 25 | 2021 |
| Computational image analysis of T-cell infiltrates in resectable gastric cancer: association with survival and molecular subtypes BR Challoner, K von Loga, A Woolston, B Griffiths, N Sivamanoharan, ... JNCI: Journal of the National Cancer Institute 113 (1), 88-98, 2021 | 24 | 2021 |
| FGFR1 amplification is often homogeneous and strongly linked to the squamous cell carcinoma subtype in esophageal carcinoma K von Loga, J Kohlhaussen, L Burkhardt, R Simon, S Steurer, ... PloS one 10 (11), e0141867, 2015 | 22 | 2015 |
| How radical should surgery be for early esophageal cancer? D Bogoevski, M Bockhorn, A Koenig, M Reeh, K von Loga, G Sauter, ... World journal of surgery 35, 1311-1320, 2011 | 21 | 2011 |
| Society for Immunotherapy of Cancer (SITC) Pathology Task Force. The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC … JM Taube, G Akturk, M Angelo, EL Engle, S Gnjatic, S Greenbaum, ... J Immunother Cancer 8 (1), e000155, 2020 | 17 | 2020 |
| Quantitative assessment and prognostic associations of the immune landscape in ovarian clear cell carcinoma S Khalique, S Nash, D Mansfield, J Wampfler, A Attygale, K Vroobel, ... Cancers 13 (15), 3854, 2021 | 13 | 2021 |
| Perioperative FLOT plus anti-PD-L1 avelumab (FLOT-A) in resectable oesophagogastric adenocarcinoma (OGA): interim safety analysis results from the ICONIC trial A Athauda, N Starling, I Chau, D Cunningham, DJ Watkins, S Rao, ... J Clin Oncol 39 (3_suppl), 201, 2021 | 13 | 2021 |
David CunninghamThe Royal Marsden NHS Foundation TrustDirección de correo verificada de rmh.nhs.uk
